SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001082554-08-000049
Filing Date
2008-05-01
Accepted
2008-05-01 18:31:41
Documents
1
Period of Report
2008-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7192
  Complete submission text file 0001082554-08-000049.txt   8952
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address
Business Address UNITED THERAPEUTIES CORP. 1110 SPRING STREET SILVERSPRING MD 20910
MAHON PAUL A (Reporting) CIK: 0001231589 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 08796093